Fig. 1From: mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysisFlowchart showing the process of identification of randomized controlled trials for inclusion in the meta-analysisBack to article page